Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Oct 31, 2025 → Jan 31, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 0 | 716,939 | 716,939 | 3.41% | $10.25M |
| ALNYLAM PHARMACEUTICALS INC | 0 | 29,936 | 29,936 | 3.37% | $10.12M |
| QIAGEN NV ORD SHARES | 0 | 150,201 | 150,201 | 2.68% | $8.06M |
| PROTAGONIST THERAPEUTICS INC | 0 | 80,859 | 80,859 | 2.20% | $6.61M |
| TG THERAPEUTICS INC | 0 | 221,373 | 221,373 | 2.17% | $6.52M |
| REPLIGEN CORP | 0 | 42,392 | 42,392 | 2.11% | $6.33M |
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 27,597 | 0 | -27,597 | 0.00% | -$11.74M |
| EXACT SCIENCES CORP | 126,347 | 0 | -126,347 | 0.00% | -$8.17M |
| SAREPTA THERAPEUTICS INC | 319,055 | 0 | -319,055 | 0.00% | -$7.66M |
| QIAGEN N.V. /EUR/ 0.00000000 | 119,237 | 0 | -119,237 | 0.00% | -$5.59M |
| CORMEDIX INC | 416,436 | 0 | -416,436 | 0.00% | -$4.63M |
| AKEBIA THERAPEUTICS INC | 1,885,407 | 0 | -1,885,407 | 0.00% | -$4.17M |
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| Invesco Private Prime Fund | 17,960,178 | 26,781,082 | 8,820,903 | 8.92% | $8.82M |
| GILEAD SCIENCES INC | 93,081 | 103,770 | 10,689 | 4.91% | $3.58M |
| AMGEN INC | 36,883 | 38,885 | 2,002 | 4.43% | $2.29M |
| UNITED THERAPEUTICS CORP DEL | 18,842 | 27,241 | 8,399 | 4.26% | $4.40M |
| Invesco Private Government Fund | 6,900,918 | 10,305,622 | 3,404,704 | 3.43% | $3.40M |
| DYNAVAX TECHNOLOGIES CORP | 558,037 | 619,803 | 61,766 | 3.20% | $3.87M |
| ACADIA PHARMACEUTICALS INC | 226,512 | 296,675 | 70,163 | 2.48% | $2.31M |
| CATALYST PHARMACEUTICALS INC | 292,174 | 301,597 | 9,423 | 2.44% | $1.11M |
| BIOMARIN PHARMACEUTICAL INC | 101,408 | 127,758 | 26,350 | 2.41% | $1.79M |
| BIO-TECHNE CORP | 102,586 | 111,680 | 9,094 | 2.38% | $738.77K |
| COLLEGIUM PHARMACEUTICAL INC | 151,110 | 155,580 | 4,470 | 2.38% | $1.70M |
| EXELIXIS INC | 151,956 | 167,824 | 15,868 | 2.31% | $1.07M |
| HALOZYME THERAPEUTICS INC | 79,864 | 95,817 | 15,953 | 2.29% | $1.66M |
| BIOCRYST PHARMACEUTICALS INC | 679,012 | 1,038,146 | 359,134 | 2.27% | $1.86M |
| NEUROCRINE BIOSCIENCES INC | 42,575 | 50,198 | 7,623 | 2.27% | $732.77K |
| VERICEL CORP | 159,832 | 182,370 | 22,538 | 2.19% | $957.96K |
| Invesco Government & Agency Portfolio, Institutional Class | 155,557 | 188,757 | 33,200 | 0.06% | $33.20K |
| Security | Shares Oct 2025 | Shares Jan 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ILLUMINA INC | 108,181 | 103,203 | -4,978 | 4.98% | $1.58M |
| BIOGEN INC | 78,120 | 73,517 | -4,603 | 4.40% | $1.17M |
| REGENERON PHARMACEUTICALS INC | 18,176 | 17,072 | -1,104 | 4.22% | $810.92K |
| INCYTE CORP | 127,154 | 122,358 | -4,796 | 4.08% | $358.01K |
| MANNKIND CORP | 1,431,429 | 1,382,171 | -49,258 | 2.66% | -$12.74K |
| IONIS PHARMACEUTICALS INC | 138,155 | 90,302 | -47,853 | 2.49% | -$2.80M |
| ROYALTY PHARMA-A | 296,857 | 178,379 | -118,478 | 2.48% | -$3.71M |
| PTC THERAPEUTICS INC | 117,792 | 88,821 | -28,971 | 2.23% | -$1.34M |
| MADRIGAL PHARMACEUTICALS INC | 13,712 | 12,061 | -1,651 | 1.97% | $157.61K |
| VERACYTE INC | 200,411 | 151,832 | -48,579 | 1.93% | -$1.45M |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.